Pathology of ANCA-associated vasculitis

Clinical and Experimental Nephrology

Volumn 17, Issue 5, 2013, Pages 652-658

  Ferrario, Franco ^a   Vanzati, Alice ^a   Pagni, Fabio ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

ANCA associated vasculitis; EGPA; GPA; MPA

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANCA ASSOCIATED VASCULITIS; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTRON MICROSCOPY; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; GRANULOMATOSIS; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; KIDNEY BIOPSY; KIDNEY INJURY; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MICROSCOPIC POLYANGIITIS; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; REVIEW;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; BIOLOGICAL MARKERS; BIOPSY; DISEASE PROGRESSION; GLOMERULONEPHRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84887243121     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0701-8     Document Type: Review

References (10)

1. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310-7.
2. Hauer HA, Bajema IM, Van Houwelingen HC, et al. Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int. 2002;62(5):1732-42.
3. Van der Woude FJ, Ferrario F. Renal involvement in ANCA-associated systemic vasculitis. J Nephrol. 1999;12(2):105-28.
4. Ferrario F, Rastaldi MP. Necrotizing-crescentic glomerulonephritis in ANCA-associated vasculitis: the role of monocytes. Nephrol Dial Transpl. 1999;14(7):1627-31.
5. Rastaldi MP, Ferrario F, Tunesi S, Yang L, D'Amico G. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules and Interleukin-1 alpha expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis. Am J Kidney Dis. 1996;27(1):48-57.
6. Berden AE, Jones RB, Erasmus DD, et al., European Vasculitis Society. Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. J Am Soc Nephrol. 2012;23(2):313-21. Epub 17 November 2011.
7. Sinico RA, Di Toma L, Maggiore U, et al. Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis. 2006;47(5):770-9.
8. Vergunst CE, van Gurp E, Hagen EC, et al. An index for renal outcome in ANCA-associated glomerulonephritis. Am J Kidney Dis. 2003;41(3):532-8.
9. Rasmussen N. Consensus therapeutic regimens for ANCA-associated systemic vasculitis. The European Community Systemic Vasculitis Study Group. Lancet. 1997;349(9057):1029-30.
10. Bajema IM, Hagen EC, Hansen BE, et al. The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement. Nephrol Dial Transpl. 1996;11(10):1989-95.